. Author manuscript; available in PMC: 2024 Apr 23.

Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2018 Jul 24;137:1–4. doi: 10.1016/j.plefa.2018.07.016

Table 2.

DHA intake estimated from dietary survey and fish oil supplementation.

	Control	Supplemented A	Supplemented B	p ^A	p ^B
Initial Ave	1.37 ± 1.00	0.38 ± 0.66	2.13 ± 0.66	0.08	0.17
Max	2.68 ± 2.18	0.78 ± 1.40	2.53 ± 1.40	0.12	0.89
Day 30 Ave	1.25 ± 1.70	0.50 ± 0.93	2.25 ± 0.93	0.38	0.25
Max	2.47 ± 3.69	1.10 ± 2.11	2.85 ± 2.11	0.46	0.84
Day 60 Ave	1.73 ± 1.65	0.17 ± 0.16	1.92 ± 0.16	0.07	0.80
Max	3.42 ± 3.60	0.35 ± 0.32	2.10 ± 0.32	0.09	0.41

The weekly docosahexaenoic acid (DHA) intake was calculated based on maternal dietary long chain polyunsaturated fatty acid (LCPUFA) intake surveyed at baseline (initial) and at days 30 and 60. The data are reported as Mean ± SD grams of DHA intake per week. The DHA intake for the supplemented group is shown in two ways; before (A) or after (B) adding DHA intake from the fish oil supplement. Statistical significance of DHA intake is indicated for A and B compared to control as p^A and p^B, respectively.